Position in ABSI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,070,224
-$380,697 QoQ
Shares Held
1,023,408
+3.5% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98.15928740052843.ToString("F0")%
Shared 1.8407125994715696.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,611,306,665 across 416 Biotechnology names. ABSI ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ABSI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,070,224 | 1,023,408 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,450,921 | 988,803 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,142,532 | 1,033,728 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,099,690 | 817,001 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,665,034 | 663,361 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,717,825 | 655,659 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,419,858 | 633,471 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $569,578 | 184,928 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $717,974 | 126,404 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $528,956 | 125,942 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $136,691 | 103,554 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $140,773 | 92,614 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $722,684 | 412,963 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $893,203 | 425,335 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,337,429 | 427,294 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,248,449 | 376,039 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,381,896 | 401,174 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,016,750 | 123,994 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,422,011 | 122,271 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||